Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

NCT03746301 · clinicaltrials.gov ↗

COMPLETED

Status

924

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-valvular Atrial Fibrillation (NVAF)

Interventions

DRUG: Rivaroxaban(Xarelto,BAY 59-7939)

Sponsor

Bayer

Collaborators

[object Object]